| |||||||
| |||||||
| |||||||
| 1 | AN ACT concerning regulation.
| ||||||
| 2 | Be it enacted by the People of the State of Illinois,
| ||||||
| 3 | represented in the General Assembly:
| ||||||
| 4 | Section 5. The Pharmacy Practice Act is amended by changing | ||||||
| 5 | Section 16c as follows: | ||||||
| 6 | (225 ILCS 85/16c) | ||||||
| 7 | (Section scheduled to be repealed on January 1, 2017) | ||||||
| 8 | Sec. 16c. Medicine locking closure package. | ||||||
| 9 | (a) As used in this Section: | ||||||
| 10 | "Medicine locking closure package" means any alphanumeric | ||||||
| 11 | combination locking closure mechanism that can only be unlocked | ||||||
| 12 | with a user-generated, resettable alphanumeric code in | ||||||
| 13 | combination with an amber prescription container that forms a | ||||||
| 14 | package that allows only the person with a prescription access | ||||||
| 15 | to the medicine. | ||||||
| 16 | "Schedule II controlled substance" means a Schedule II | ||||||
| 17 | controlled substance under the United States Controlled | ||||||
| 18 | Substances Act and 21 CFR 1308. | ||||||
| 19 | (b) Subject to appropriation, effective January 1, 2016, | ||||||
| 20 | the Department shall by rule implement a pilot project | ||||||
| 21 | requiring that every new or refilled prescription for a | ||||||
| 22 | Schedule II controlled substance containing hydrocodone | ||||||
| 23 | dispensed by a pharmacy that voluntarily decides to participate | ||||||
| |||||||
| |||||||
| 1 | in the pilot program shall only be dispensed in a non-reusable | ||||||
| 2 | medicine locking closure package. The Department shall not | ||||||
| 3 | expend more than $150,000 on this pilot program. The Department | ||||||
| 4 | may contract with third parties to implement the pilot program | ||||||
| 5 | in whole or in part. | ||||||
| 6 | (c) The medicine locking closure package must be dispensed | ||||||
| 7 | by the pharmacy with instructions for patient use unless the | ||||||
| 8 | prescriber indicates orally, in writing, or electronically | ||||||
| 9 | that a medicine locking closure package shall not be used. | ||||||
| 10 | (d) The manufacturer of the medicine locking closure | ||||||
| 11 | package must make available assistance online or through a | ||||||
| 12 | toll-free number for patient use. | ||||||
| 13 | (e) Prescriptions reimbursed via the Medicare Part D and | ||||||
| 14 | Medicaid programs, including Medicaid managed care plans, are | ||||||
| 15 | exempt from the provisions of this Section. | ||||||
| 16 | (f) Prescriptions for individuals residing in facilities | ||||||
| 17 | licensed under the Nursing Home Care Act are exempt from the | ||||||
| 18 | provisions of this Section. | ||||||
| 19 | (g) This Section is repealed on January 1, 2018 2017.
| ||||||
| 20 | (Source: P.A. 99-473, eff. 8-27-15.)
| ||||||
| 21 | Section 99. Effective date. This Act takes effect upon | ||||||
| 22 | becoming law.
| ||||||